Centers for Disease Control - CGH

Description

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients.Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure.

Who can apply

• Unrestricted

Contact

Emily Dale<br/>dln6@cdc.gov
dln6@cdc.gov